全文获取类型
收费全文 | 1998篇 |
免费 | 150篇 |
国内免费 | 80篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 78篇 |
妇产科学 | 17篇 |
基础医学 | 262篇 |
口腔科学 | 27篇 |
临床医学 | 305篇 |
内科学 | 386篇 |
皮肤病学 | 34篇 |
神经病学 | 189篇 |
特种医学 | 389篇 |
外科学 | 131篇 |
综合类 | 86篇 |
预防医学 | 98篇 |
眼科学 | 9篇 |
药学 | 141篇 |
中国医学 | 1篇 |
肿瘤学 | 69篇 |
出版年
2021年 | 14篇 |
2019年 | 15篇 |
2018年 | 19篇 |
2017年 | 14篇 |
2016年 | 22篇 |
2015年 | 30篇 |
2014年 | 18篇 |
2013年 | 35篇 |
2012年 | 34篇 |
2011年 | 61篇 |
2010年 | 62篇 |
2009年 | 64篇 |
2008年 | 66篇 |
2007年 | 90篇 |
2006年 | 61篇 |
2005年 | 63篇 |
2004年 | 37篇 |
2003年 | 50篇 |
2002年 | 44篇 |
2001年 | 57篇 |
2000年 | 47篇 |
1999年 | 44篇 |
1998年 | 109篇 |
1997年 | 95篇 |
1996年 | 131篇 |
1995年 | 101篇 |
1994年 | 106篇 |
1993年 | 88篇 |
1992年 | 41篇 |
1991年 | 43篇 |
1990年 | 50篇 |
1989年 | 41篇 |
1988年 | 44篇 |
1987年 | 37篇 |
1986年 | 48篇 |
1985年 | 47篇 |
1984年 | 22篇 |
1983年 | 33篇 |
1982年 | 25篇 |
1981年 | 35篇 |
1980年 | 24篇 |
1979年 | 11篇 |
1978年 | 23篇 |
1977年 | 26篇 |
1976年 | 16篇 |
1975年 | 16篇 |
1974年 | 9篇 |
1972年 | 6篇 |
1971年 | 10篇 |
1966年 | 6篇 |
排序方式: 共有2228条查询结果,搜索用时 15 毫秒
1.
Mice are a widely utilized in vivo model for translational salivary gland research but must be used with caution. Specifically, mouse salivary glands are similar in many ways to human salivary glands (i.e., in terms of their anatomy, histology, and physiology) and are both readily available and relatively easy and affordable to maintain. However, there are some significant differences between the two organisms, and by extension, the salivary glands derived from them must be taken into account for translational studies. The current review details pertinent similarities and differences between human and mouse salivary glands and offers practical guidelines for using both for research purposes. 相似文献
2.
3.
4.
5.
Zhaorui Lian Eric K Lee Adam J Bass Kwok K Wong Andres JP Klein-Szanto Anil K Rustgi J Alan Diehl 《Cancer biology & therapy》2015,16(5):750-755
Cyclin D1 is frequently overexpressed in esophageal squamous cell carcinoma (ESCC) and is considered a key driver of this disease. Mutations in FBXO4, F-box specificity factor that directs SCF-mediated ubiquitylation of cyclin D1, occur in ESCC with concurrent overexpression of cyclin D1 suggesting a potential tumor suppressor role for FBXO4. To evaluate the contribution of FBXO4-dependent regulation cyclin D1 in esophageal squamous cell homeostasis, we exposed FBXO4 knockout mice to N-nitrosomethylbenzylamine (NMBA), an esophageal carcinogen. Our results revealed that loss of FBXO4 function facilitates NMBA induced papillomas in FBXO4 het (+/−) and null (−/−) mice both by numbers and sizes 11 months after single dose NMBA treatment at 2mg/kg by gavage when compared to that in wt (+/+) mice (P < 0.01). No significant difference was noted between heterozygous or nullizygous mice consistent with previous work. To assess cyclin D1/CDK4 dependence, mice were treated with the CDK4/6 specific inhibitor, PD0332991, for 4 weeks. PD0332991 treatment (150mg/kg daily), reduced tumor size and tumor number. Collectively, our data support a role for FBXO4 as a suppressor of esophageal tumorigenesis. 相似文献
6.
Marleen Straat Marcella CA Müller Joost CM Meijers Mendi S Arbous Angelique ME Spoelstra - de Man Charlotte JP Beurskens Margreeth B Vroom Nicole P Juffermans 《Critical care (London, England)》2015,19(1)
IntroductionMuch controversy exists on the effect of a fresh frozen plasma (FFP) transfusion on systemic inflammation and endothelial damage. Adverse effects of FFP have been well described, including acute lung injury. However, it is also suggested that a higher amount of FFP decreases mortality in trauma patients requiring a massive transfusion. Furthermore, FFP has an endothelial stabilizing effect in experimental models. We investigated the effect of fresh frozen plasma transfusion on systemic inflammation and endothelial condition.MethodsA prospective predefined substudy of a randomized trial in coagulopathic non-bleeding critically ill patients receiving a prophylactic transfusion of FFP (12 ml/kg) prior to an invasive procedure. Levels of inflammatory cytokines and markers of endothelial condition were measured in paired samples of 33 patients before and after transfusion. The statistical tests used were paired t test or the Wilcoxon signed-rank test.ResultsAt baseline, systemic cytokine levels were mildly elevated in critically ill patients. FFP transfusion resulted in a decrease of levels of TNF-α (from 11.3 to 2.3 pg/ml, P = 0.01). Other cytokines were not affected. FFP also resulted in a decrease in systemic syndecan-1 levels (from 675 to 565 pg/ml, P = 0.01) and a decrease in factor VIII levels (from 246 to 246%, P <0.01), suggestive of an improved endothelial condition. This was associated with an increase in ADAMTS13 levels (from 24 to 32%, P <0.01) and a concomitant decrease in von Willebrand factor (vWF) levels (from 474 to 423%, P <0.01).ConclusionsA fixed dose of FFP transfusion in critically ill patients decreases syndecan-1 and factor VIII levels, suggesting a stabilized endothelial condition, possibly by increasing ADAMTS13, which is capable of cleaving vWF.
Trial registrations
Trialregister.nl NTR2262, registered 26 March 2010 and Clinicaltrials.gov , registered 14 June 2010. NCT01143909相似文献7.
8.
9.
10.